| Literature DB >> 31172912 |
Eva Wattrang1, Victoria Jäderblom1, Tomas Jinnerot1, Helena Eriksson2, Elisabeth Bagge1,2, Maria Persson2, Tina Sørensen Dalgaard3, Robert Söderlund1.
Abstract
PURPOSE: The present study aimed to establish pretreatment protocols as well as real-time and droplet digital polymerase chain reaction (PCR) methodologies to detect and quantify Erysipelothrix rhusiopathiae (ER) DNA in blood samples from infected chickens, as tools for routine diagnostics and monitoring of experimental infections. Chicken blood is a problematic matrix for PCR analysis because nucleated erythrocytes contribute large amounts of host DNA that inhibit amplification.Entities:
Keywords: Erysipelothrix rhusiopathiae; blood; chicken; droplet digital PCR; nucleated erythrocyte; real-time polymerase chain reaction (PCR)
Mesh:
Substances:
Year: 2019 PMID: 31172912 PMCID: PMC6939158 DOI: 10.1099/jmm.0.001016
Source DB: PubMed Journal: J Med Microbiol ISSN: 0022-2615 Impact factor: 2.472
Fig. 4.A selection of results from blood samples from ER-infected chickens (infection trial 3) analysed for bacterial DNA by ddPCR. Each lane (indicated by Pos., Neg. and a–eE) show the combined results from triplicate reactions of the same sample. The vertical axis shows the end-point probe fluorescence of each droplet PCR reaction in arbitrary units. Each individual event (droplet) evaluated after the completed PCR protocol is shown as a dot along the horizontal axis. Blue dots represent high-fluorescence positive events, i.e. droplets that contained one or more target DNA molecules. Grey dots represent negative events with low fluorescence levels, where no target DNA was present in the droplet. The purple line (4000 AU) represent the threshold level for positive events. Between 21570 and 33692 events were analysed for each of these samples. (a) Undiluted and (b) 1:10 dilution of DNA from chicken 25 day 3; (c) undiluted and (d) 1 : 10 dilution of DNA from chicken 38 day 3; (e) undiluted DNA from chicken 20 day 1; Pos., positive control with ER DNA; Neg., no-template control. For comprehensive results, see table S5.
Fig. 1.Proportions (%) of blood samples positive for growth of ER or positive for ER DNA quantified by real-time PCR, respectively, at the indicated days. Blood samples were collected from chickens experimentally infected with ER on day 0. (a) Infection trial 1: culture of ER was performed in selective sodium azide/crystal violet broth (dark blue circles) and real-time PCR was performed on samples prepared according to protocol A, cell-free (CFF; dark green squares). (b) Infection trial 2: culture of ER was performed directly on horse blood agar (light blue circles) and real-time PCR was performed on samples prepared according to protocol C, Ficoll (FS; light green squares). (c) Infection trial 3: culture of ER was performed directly on horse blood agar with blood from unvaccinated chickens (light blue circles) or chickens vaccinated against erysipelas (light blue triangles) and real-time PCR was performed on samples prepared according to protocol C, FS, with blood from unvaccinated chickens (light green squares) or chickens vaccinated against erysipelas (light green diamonds). For details see the Methods section.
Fig. 2.ER DNA quantified by real-time PCR in samples of heparin-stabilized (green bars) or EDTA-stabilized (light purple bars) chicken blood incubated at 40 °C for 4 or 16 h. After incubation, blood samples were prepared for DNA extraction in parallel using three different protocols: A, cell-free (CFF); B, slow-speed (SSC); C, Ficoll (FS); for details see the Methods section. The results are shown as the means of two technical replicates in the real-time PCR ±1 sd.
Fig. 3.Correlation between c.f.u. of ER detected by culture and genome copies of ER DNA detected by real-time PCR (red filled circles) or by ddPCR (crosses) in blood from experimentally ER infected chickens in infection trials 2 and 3. Only samples that were deemed positive by both methods are shown and on those occasions where DNA samples were positive when both undiluted and in dilution, 1 : 10 results from the 1 : 10 dilution are shown. For comprehensive results, see Tables S3 and S5.